Stay updated on Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial

Sign up to get notified when there's something new on the Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T06:32:45.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content removal regarding a clinical study on SARS-CoV-2, including details about hyper-inflammation and treatment options, while adding a new revision number and a specific EudraCT number for a study.
    Difference
    25%
    Check dated 2025-04-16T20:54:27.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.14.3 to v2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T16:09:21.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-02T00:34:11.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T23:28:46.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T17:58:41.000Z thumbnail image

Stay in the know with updates to Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial page.